MYC-amplified cancer cells are characterized by inadequate reduction/oxidation balance with accumulation of reactive oxygen species, accelerated entry in S phase and impairment in the expression of genes implicated in purine and pyrimidine biosynthesis and in the regulation of the HR pathway[66,67]. The gene discussed is MYC; the disease is cancer.